LakeShore Biopharma Co Ltd (LSB)
2.71
-0.39
(-12.58%)
USD |
NASDAQ |
Nov 14, 16:00
2.71
0.00 (0.00%)
After-Hours: 20:00
LakeShore Biopharma EPS Diluted (Quarterly): -0.1565 for Sept. 30, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -1.565 |
| June 30, 2023 | -1.066 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.4615 |
| June 30, 2022 | -0.8873 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-1.565
Minimum
Sep 2023
-0.4615
Maximum
Sep 2022
-0.9951
Average
-0.9768
Median
EPS Diluted (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | -0.52 |
| Zai Lab Ltd | -0.80 |
| China SXT Pharmaceuticals Inc | -- |
| Adagene Inc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.51M |
| Revenue (Quarterly) | 13.38M |
| Total Expenses (Quarterly) | 27.21M |